135 related articles for article (PubMed ID: 4015071)
21. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
22. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
Manzione BM; Bernstein JR; Franklin RB
Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422
[TBL] [Abstract][Full Text] [Related]
23. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
24. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey.
Miyamoto G; Sasabe H
Arzneimittelforschung; 1984; 34(3A):394-402. PubMed ID: 6540095
[TBL] [Abstract][Full Text] [Related]
26. Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.
Iravani A; Welty GS; Newton BR; Richard GA
Antimicrob Agents Chemother; 1985 Apr; 27(4):449-51. PubMed ID: 3890724
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.
Cretton EM; Zhou Z; Kidd LB; McClure HM; Kaul S; Hitchcock MJ; Sommadossi JP
Antimicrob Agents Chemother; 1993 Sep; 37(9):1816-25. PubMed ID: 8239589
[TBL] [Abstract][Full Text] [Related]
28. High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals.
Kusajima H; Ooie T; Kawahara F; Uchida H
J Chromatogr; 1986 Aug; 381(1):137-48. PubMed ID: 3095363
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
30. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
31. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
John JF; Twitty JA
Antimicrob Agents Chemother; 1984 Nov; 26(5):781-4. PubMed ID: 6440481
[TBL] [Abstract][Full Text] [Related]
32. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
33. The disposition and urinary metabolism of 14C-labelled FCE 22891, a pro-drug of FCE 22101, in animals.
Battaglia R; Benedetti MS; Frigerio E; Vicario G; Roncucci R
J Antimicrob Chemother; 1990 Jan; 25(1):133-9. PubMed ID: 2318748
[TBL] [Abstract][Full Text] [Related]
34. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
Bechtel WD; Mierau J; Richter I; Stiasni M
Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
[TBL] [Abstract][Full Text] [Related]
35. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Thompson KD; O'Keefe JP; Tatarowicz WA
Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.
Salmon J; Coussediere D; Cousty C; Raynaud JP
J Steroid Biochem; 1983 Aug; 19(2):1223-34. PubMed ID: 6887930
[TBL] [Abstract][Full Text] [Related]
37. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
39. Disposition and metabolism of [14C]sparfloxacin in the rat.
Matsunaga Y; Miyazaki H; Oh-e Y; Nambu K; Furukawa H; Yoshida K; Hashimoto M
Arzneimittelforschung; 1991 Jul; 41(7):747-59. PubMed ID: 1663354
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.
Girard D; Gootz TD; McGuirk PR
Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
